Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2021 Feb 18

PMID 33596783

Citations 17

Authors

Yanfang Chen

Zheng Chen

Jian Mo

Mao Pang

Zihao Chen

Feng Feng

Peigen Xie

Bu Yang

Affiliations

Soon will be listed here.

Abstract

Background: Bone metastasis is a leading cause of the high mortality rate of prostate cancer (PCa), but curative strategies remain lacking. Recent studies suggest long non-coding RNAs (lncRNAs) may be potential targets to develop drugs. However, PCa bone metastasis-specifically-related lncRNAs were rarely reported. This study aimed to identify crucial lncRNAs and reveal their function mechanisms.

Methods: GSE32269 and GSE26964 microarray datasets, downloaded from the Gene Expression Omnibus database, were used to analyze differentially expressed genes (DEGs)/lncRNAs (DELs) and miRNAs (DEMs), respectively. Weighted gene co-expression network analysis was performed to screen PCa bone metastasis-associated modules. The co-expression and competing endogenous RNAs (ceRNAs) networks were constructed to identify hub lncRNAs. Univariate Cox regression analysis was conducted to determine their prognostic values. The correlation of lncRNAs with immune infiltrating cells was analyzed by using Tumor IMmune Estimation Resource. Therapeutic drugs were predicted by querying the Connectivity Map (CMap) and the Comparative Toxicogenomics Database (CTD).

Results: A total of 18 DELs, 2,614 DEGs and 86 DEMs were screened between bone metastatic and primary PCa samples. Four modules enriched by DEGs were shown to be bone metastasis-associated. LncRNA HCG18 and MCM3AP-AS1 were identified to be important because they existed in both of the co-expression and ceRNA networks (forming the relationship pairs: HCG18/MCM3AP-AS1-KNTC1, MCM3AP-AS1-hsa-miR-508-3p-DTL and HCG18/MCM3AP-AS1-hsa-miR-127-3p-CDKN3). All the genes in these interaction pairs were significantly associated with overall survival of PCa patients. Also, HCG18, MCM3AP-AS1 and their target mRNAs were positively correlated with various tumor-infiltrated immune cells, especially increased M2 macrophages. Valproic acid and trichostatin A may be effective to treat PCa bone metastasis by targeting HCG18 and MCM3AP-AS1.

Conclusion: HCG18 and MCM3AP-AS1 that regulate M2 macrophage infiltration may be important targets to treat PCa bone metastasis and improve prognosis.

Citing Articles

Unveiling Racial Disparities in Localized Prostate Cancer: A Systems-Level Exploration of the lncRNA Landscape.

Morgan R, Hazard E, Savage S, Halbert C, Gattoni-Celli S, Hardiman G Genes (Basel). 2025; 16(2).

PMID: 40004558 PMC: 11855151. DOI: 10.3390/genes16020229.

LncRNA promotes prostate cancer progression by regulating the miR-512-3p/HK-2 axis.

Zhu Y, Wang Z, Li H, Ren Z, Zi T, Qin X Asian J Urol. 2024; 11(4):575-585.

PMID: 39533994 PMC: 11551385. DOI: 10.1016/j.ajur.2024.01.007.

Overexpression of Long Non-coding RNAs and Predict Poor Prognosis in Patients with Gastric Adenocarcinoma.

Bagheri M, Aghaabdollahian S, Rezaei M, Gholian Kholerdi A, Raei M, Keyvanloo Shahrestanaki M Adv Biomed Res. 2024; 13:34.

PMID: 39234433 PMC: 11373733. DOI: 10.4103/abr.abr_308_23.

The role of Cyclin Dependent Kinase Inhibitor 3 () in promoting human tumors: Literature review and pan-cancer analysis.

Zhang C, Shen Q, Gao M, Li J, Pang B Heliyon. 2024; 10(4):e26061.

PMID: 38380029 PMC: 10877342. DOI: 10.1016/j.heliyon.2024.e26061.

Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer.

Gao C, Fan X, Liu Y, Han Y, Liu S, Li H Int J Gen Med. 2023; 16:5817-5839.

PMID: 38106976 PMC: 10723185. DOI: 10.2147/IJGM.S438479.

References

Li X, Yu M, Yang C . YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis. J Cell Biochem. 2019; 121(3):2258-2267. DOI: 10.1002/jcb.29448. View

Fortson W, Kayarthodi S, Fujimura Y, Xu H, Matthews R, Grizzle W . Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. Int J Oncol. 2011; 39(1):111-9. PMC: 3329756. DOI: 10.3892/ijo.2011.1014. View

Xiang P, Jin S, Yang Y, Sheng J, He Q, Song Y . Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling. Prostate. 2019; 79(9):1018-1031. PMC: 6594129. DOI: 10.1002/pros.23810. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Yang M, Sun S, Guo Y, Qin J, Liu G . Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer. Mol Med. 2019; 25(1):55. PMC: 6909501. DOI: 10.1186/s10020-019-0121-2. View

Li Y, Huo C, Lin X, Xu J . Computational Identification of Cross-Talking ceRNAs. Adv Exp Med Biol. 2018; 1094:97-108. DOI: 10.1007/978-981-13-0719-5_10. View

Cao J, Zhang S . A Bayesian extension of the hypergeometric test for functional enrichment analysis. Biometrics. 2013; 70(1):84-94. PMC: 3954234. DOI: 10.1111/biom.12122. View

Lang C, Dai Y, Wu Z, Yang Q, He S, Zhang X . SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis. Mol Oncol. 2020; 14(4):808-828. PMC: 7138406. DOI: 10.1002/1878-0261.12634. View

Wang W, Zhao Z, Yang F, Wang H, Wu F, Liang T . An immune-related lncRNA signature for patients with anaplastic gliomas. J Neurooncol. 2017; 136(2):263-271. DOI: 10.1007/s11060-017-2667-6. View

10.

Kobayashi H, Komatsu S, Ichikawa D, Kawaguchi T, Hirajima S, Miyamae M . Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma. Oncotarget. 2015; 6(34):36615-24. PMC: 4742199. DOI: 10.18632/oncotarget.5620. View

11.

Cai C, Wang H, He H, Chen S, He L, Ma F . ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. J Clin Invest. 2013; 123(3):1109-22. PMC: 3582143. DOI: 10.1172/JCI66666. View

12.

Song Z, Chao F, Zhuo Z, Ma Z, Li W, Chen G . Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis. Aging (Albany NY). 2019; 11(13):4736-4756. PMC: 6660050. DOI: 10.18632/aging.102087. View

13.

Lan X, Lu G, Yuan C, Mao S, Jiang W, Chen Y . Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. J Cancer Res Clin Oncol. 2015; 142(1):177-85. DOI: 10.1007/s00432-015-2020-4. View

14.

Li S, Wu T, Zhang D, Sun X, Zhang X . The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/β-catenin. Clin Exp Pharmacol Physiol. 2019; 47(4):703-712. DOI: 10.1111/1440-1681.13230. View

15.

Wang Z, Wang Y, Peng M, Yi L . UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer. Front Oncol. 2020; 9:1517. PMC: 6974685. DOI: 10.3389/fonc.2019.01517. View

16.

Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R . Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. J Cell Biochem. 2017; 119(3):2951-2963. DOI: 10.1002/jcb.26509. View

17.

Guo S, Zeng H, Huang P, Wang S, Xie C, Li S . MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Eur Rev Med Pharmacol Sci. 2018; 22(19):6379-6385. DOI: 10.26355/eurrev_201810_16050. View

18.

Cui H, Wang Q, Lei Z, Feng M, Zhao Z, Wang Y . DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation. J Exp Clin Cancer Res. 2019; 38(1):350. PMC: 6693180. DOI: 10.1186/s13046-019-1358-x. View

19.

Li L, Ma T, Ma Y, Jiang Y . LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway. Eur Rev Med Pharmacol Sci. 2019; 23(23):10387-10399. DOI: 10.26355/eurrev_201912_19678. View

20.

Liang M, Jia J, Chen L, Wei B, Guan Q, Ding Z . LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Endocrine. 2019; 65(2):318-326. DOI: 10.1007/s12020-019-01939-4. View